Geographic expansion EU and US market readiness with CE mark for Dr Yglo and plans to launch in Italy, Portugal, Estonia, Latvia, Lithuania, and the US indicate opportunity for multi-region distribution partnerships and localized sales initiatives.

Private label potential Strong portfolio of self-care OTC brands across dermatology, antifungal, ENT and menopause segments plus a growing distribution network suggests opportunities for co-branding, white-labeling, or exclusive regional rights with retailers and e-commerce platforms.

Regulatory credibility ISO 13485 certification and B Corporation status reinforce safety, quality, and sustainability credentials, enabling conversations with larger retailers, hospital networks, and procurement teams that prioritize compliant medical devices and consumer health products.

Leadership experience Management team with a track record across Europe and recent strategic hires in key markets (Germany) signal capacity to scale partnerships, manage regulatory pathways, and execute expansion deals with distributors and importers.

Digital and e-commerce readiness Integrated tech stack (WordPress, Dynamics, Adobe, e-commerce-ready content) supports digital marketing, cross-border commerce, and channel partner portals, enabling streamlined lead generation, partner onboarding, and order fulfillment.